Company intelligence / Profile preview

Glucona America

Janesville, Wisconsin, United States

Ownership: Private
Development stage: Other

Overview

Glucona America was a specialized manufacturer of gluconic acid and its derivatives, primarily serving the pharmaceutical, food, and industrial sectors. The company was a key North American component of Glucona B.V., a joint venture between Akzo Nobel and Avebe. Its product portfolio included sodium gluconate and various mineral gluconates used as excipients, mineral supplements, and high-performance chelating agents. In 2004, the business was acquired by Roquette, which integrated Glucona's operations into its global bio-refinery and ingredient network.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Chemicals & Materials

Partnerships

Akzo NobelAvebe

Beyond the preview

Go deeper on Glucona America.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucona America.

Explore the full profile